Human Longevity, Inc. — Form D/A
Human Longevity, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2024-08-21. The offering totals $32.0M, of which $32.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-08-21
- Form: D/A
- Accession: 0001781303-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $32.0M
- Amount sold: $32.0M
- Investors: 18
- Date of first sale: 2023-03-13
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-478201
Issuer
- Name: Human Longevity, Inc.
- CIK: 0001781303
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 4570 EXECUTIVE DRIVE, SAN DIEGO, CA, 92121
- Phone: 844-838-3322
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Wei-Wu He | Director | Rockville, MD |
| James Hu | Director | Rockville, MD |
| James Huang | Director | South San Francisco, CA |
| David Karow | Director | San Diego, CA |
| Helmut Schuehsler | Director | Singapore, U0 |
| James Hu | Executive Officer | Rockville, MD |
| David Karow | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More